Biomarkers of sepsis

References

• Levy MM, Dellinger RP, Townsend SR, et al. The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Intensive Care Med 2010;36:222–31
   PubMed Web of Science ®Google Scholar
• Hall MJ, Williams SN, DeFrances CJ, Golosinsky A. Inpatient care for septicemia or sepsis: a challenge for patients and hospitals. National Center for Health Statistics Data Brief No. 62. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Jun 2011. Available from: http://www.cdc.gov/nchs/data/databriefs/db62.htm [last accessed 2 Jan 2013]
   Google Scholar
• Wang HE, Shapiro NI, Angus DC, Yealy DM. National estimates of severe sepsis in United States emergency departments. Crit Care Med 2007;35:1928–36
   PubMed Web of Science ®Google Scholar
• Ulevitch RJ, Tobias PS. Recognition of gram-negative bacteria and endotoxin by the innate immune system. Curr Opin Immunol 1999;11:19–22
   PubMed Web of Science ®Google Scholar
• Kumar H, Kawai T, Akira S. Pathogen recognition by the innate immune system. Int Rev Immunol 2011;30:16–34
   PubMed Web of Science ®Google Scholar
• American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864–74
   PubMed Web of Science ®Google Scholar
• Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003;31:1250–6
   PubMed Web of Science ®Google Scholar
• Balk R, Roger C. Bone, MD and the evolving paradigms of sepsis. Contrib Microbiol 2011;17:1–11
   PubMedGoogle Scholar
• Bone RC, Grodzin CJ, Balk RA. Sepsis: a new hypothesis for pathogenesis of the disease process. Chest 1997;112:235–43
   PubMed Web of Science ®Google Scholar
• Choileain NN, Redmond HP. The immunological consequences of injury. Surgeon 2006;4:23–31
   PubMed Web of Science ®Google Scholar
• Chung LP, Waterer GW. Genetic predisposition to respiratory infection and sepsis. Crit Rev Clin Lab Sci 2011;48:250–68
   PubMed Web of Science ®Google Scholar
• Bone RC, Fisher JC Jr, Clemmer TP, et al. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Eng J Med 1987;317:653–8
   PubMed Web of Science ®Google Scholar
• Karzai W, Oberhoffer M, Meier-Hellmann A, Reinhart K. Procalcitonin: a new indicator of the systemic response to severe infections. Infection 1997;25:329–34
   PubMed Web of Science ®Google Scholar
• Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Eng J Med 2001;345:1368–77
   PubMed Web of Science ®Google Scholar
• Christaki E, Anyfanti P, Opal SM. Immunomodulatory therapy for sepsis: an update. Expert Rev Anti Infect Ther 2011;9:1013–33
   PubMed Web of Science ®Google Scholar
• Ghezzi P, Cerami A. Tumor necrosis factor as a pharmacological target. Methods Mol Med 2004;98:1–8
   PubMedGoogle Scholar
• Qui P, Cui X, Barochia A, Li Y, et al. The evolving experience with therapeutic TNF inhibition in sepsis: considering the potential influence of risk of death. Expert Opin Investig Drugs 2011;20:1555–64
   PubMed Web of Science ®Google Scholar
• Rice TW, Wheeler AP, Morris PE, et al. Safety and efficacy of affinity-purified, anti-tumor necrosis factor-alpha, ovine fab for injection CytoFab in severe sepsis. Crit Care Med 2006;34:2271–81
   PubMed Web of Science ®Google Scholar
• Cannon JG, Tompkins RG, Gelfand JA, et al. Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever. J Infect Dis 1990;161:79–84
   PubMed Web of Science ®Google Scholar
• Jooster LA, van de Veerdonk FL, Vonk AG, et al. Differential susceptibility to lethal endtoxinaemia in mice deficient in IL-1α, IL-1β, or IL-1 receptor type I. APMIS 2010;118:1000–7
   PubMed Web of Science ®Google Scholar
• Batfalsky A, Lohr A, Heussen N, et al. Diagnostic value of an interleukin-6 bedside test in term and preterm neonates at the time of clinical suspicion of early- and late-onset bacterial infection. Neonatology 2012;102:37–44
   PubMed Web of Science ®Google Scholar
• Patel RT, Deen KI, Korings D, Warwick J, Keighley MR. Interleukin-6 is a prognostic indicator of outcome in severe intra-abdominal sepsis. Br J Surg 1994;81:1306–8
   PubMed Web of Science ®Google Scholar
• Petilla V, Hynninen M, Takkunen O, et al. Predictive value of procalcitonin and interleukin 6 in critically ill patients with suspected sepsis. Intensive Care Med 2002;28:1220–5
   PubMed Web of Science ®Google Scholar
• Panacek EA, Marshall JC, Albertson TE, et al. Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody Fab’2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels. Crit Care Med 2004;32:2173–82
   PubMed Web of Science ®Google Scholar
• Osuchowski MF, Connett J, Welch K, et al. Stratification is the key: inflammatory biomarkers accurately direct immunomodulatory therapy in experimental sepsis. Crit Care Med 2009;37:1567–73
   PubMed Web of Science ®Google Scholar
• Eliasson M, Egesten A. Antibacterial chemokines: actors in both innate and adaptive immunity. In: Herwald H, Egesten A, eds. Trends in innate immunity. Basel: Karger; Contrib Microbiol 2008;15:101–17
   Google Scholar
• Stryjewski GR, Nylen ES, Bell MJ, et al. Interleukin-6, interleukin-8, and a rapid and sensitive assay for calcitonin precursors for the determination of bacterial sepsis in febrile neutropenic children. Pediatr Crit Care Med 2005;6:129–35
   PubMedGoogle Scholar
• Bozza FA, Salluh JI, Japiassu AM, et al. Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis. Crit Care 2007;11:R49
   PubMed Web of Science ®Google Scholar
• Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Eng J Med 1999;340:448–54
   PubMed Web of Science ®Google Scholar
• Jaye DL, Waites KB. Clinical applications of c-reactive protein in pediatrics. Ped Infect Dis 1997;16:735–8
   Google Scholar
• Benzaquen LR, Yu H, Rifai N. High-sensitivity C-reactive protein: an emerging role in cardiovascular risk assessment. Crit Rev Clin Lab Sci 2002;39:459–97
   PubMed Web of Science ®Google Scholar
• Hofer N, Zacharias E, Muller W, Resch B. An update on the use of C-reactive protein in early-onset neonatal sepsis: current insights and new tasks. Neonatology 2012;102:25–36
   PubMed Web of Science ®Google Scholar
• Welsch T, Frommhold K, Hinz U, et al. Persisting elevation of C-reactive protein after pancreatic resections can indicate developing inflammatory complications. Surgery 2008;143:20–28
   PubMed Web of Science ®Google Scholar
• Mauri T, Bellani G, Patroniti N, et al. Persisting high levels of plasma pentraxin 3 over the first days after severe sepsis and septic shock onset are associated with mortality. Intensive Care Med 2010;36:621–29
   PubMed Web of Science ®Google Scholar
• Assicot M, Gendrel D. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993;341:515–8
   PubMed Web of Science ®Google Scholar
• Muller B, White JC, Nylen ES, et al. Ubiquitous expression of the calcitonin-I gene in multiple tissues in response to sepsis. J Clin Endocrinol Metab 2001;86:396–404
   PubMed Web of Science ®Google Scholar
• Tavares E, Minano FJ. Immunoneutralization of the aminoprocalcitonin peptide of procalcitonin protects rats from lethal endotoxaemias: neuroendocrine and systemic studies. Clin Sci 2010;119:519–34
   Web of Science ®Google Scholar
• O’Grady NP, Barie PS, Bartlett JG, et al. American College of Critical Care Medicine; Infectious Diseases Society of America. Guidelines for evaluation of new fever in critically ill adult patients: 2008 update from the American College of Critical Care Medicine and the Infectious Diseases Society of America. Crit Care Med 2008;36:1330–40
   PubMed Web of Science ®Google Scholar
• Simon L, Gauvin F, Amre DK, et al. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 2004;39:206–17
   PubMed Web of Science ®Google Scholar
• Chirouze C, Schuhmacher H, Rabaud C, et al. Low serum procalcitonin level accurately predicts the absence of bacteremia in adult patients with acute fever. Clin Infect Dis 2002;35:156–61
   PubMed Web of Science ®Google Scholar
• Nakamura A, Wada H, Ikejiri M, et al. Efficacy of procalcitonin in the early diagnosis of bacterial infections in a critical care unit. Shock 2009;31:586–91
   PubMed Web of Science ®Google Scholar
• Riedel S, Melendez JH, An AT, et al. Procalcitonin as a marker for the detection of bacteremia and sepsis in the Emergency Department. Am J Clin Pathol 2011;135:190–9
   PubMed Web of Science ®Google Scholar
• Uzzan B, Cohen R, Nicolas P, et al. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med 2006;34:1996–2003
   PubMed Web of Science ®Google Scholar
• Yu Z, Liu J, Sun Q, et al. The accuracy of the procalcitonin test for the diagnosis of neonatal sepsis: a meta-analysis. Scand J Infect Dis 2010;42:723–33
   PubMed Web of Science ®Google Scholar
• Mann EA, Wood GI, Wade CE. Use of procalcitonin for the detection of sepsis in the critically ill burn patient: a systemic review of the literature. Burns 2011;37:549–58
   PubMed Web of Science ®Google Scholar
• Tang BMP, Eslick GD, Craig JC, McLean AS. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systemic review and meta-analysis. Lancet Infect Dis 2007;7:210–17
   PubMed Web of Science ®Google Scholar
• Reinhart K, Brunkhorst FM. Meta-analysis of procalcitonin for sepsis detection. Lancet Infect Dis 2007;7:500–2
   PubMed Web of Science ®Google Scholar
• Becker KL, Snider R, Nylen ES. Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations. Crit Care Med 2008;36:941–52
   PubMed Web of Science ®Google Scholar
• Billeter A, Turina M, Seifert B, et al. Early serum procalcitonin, interleukin-6, and 24-hour lactate clearance: useful indicators of septic infections in severely traumatized patients. World J Surg 2009;33:558–66
   PubMed Web of Science ®Google Scholar
• Clec’h C, Fosse JP, Karoubi P, et al. Differential diagnostic value of procalcitonin in surgical and medical patients with septic shock. Crit Care Med 2006;34:102–7
   PubMed Web of Science ®Google Scholar
• Brunkhorst FM, Al-Nawas B, Krummenauer F, et al. Procalcitonin, c-reactive protein and APACHE II score for risk evaluation in patients with severe pneumonia. Clin Microbiol Infect 2002;8:93–100
   PubMed Web of Science ®Google Scholar
• Bele N, Darmon M, Coquet I, et al. Diagnostic accuracy of procalcitonin in critically ill immunocompromised patients. BMC Infect Dis 2011;11:224
   PubMed Web of Science ®Google Scholar
• Jensen JU, Hein L, Lundgren B, et al. Procalcitonin and Survival Study PASS Group. Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial. Crit Care Med 2011;39:2048–58
   PubMed Web of Science ®Google Scholar
• Jensen JU, Hein L, Lundgren B, et al. Procalcitonin and Survival Study PASS Group. Kidney failure related to broad-spectrum antibiotics in critically ill patients: secondary end point results from a 1200 patient randomized trial. BMJ Open 2012;2:e000635
   PubMed Web of Science ®Google Scholar
• Scheutz P, Chiappa V, Briel M, Greenwald JL. Procalcitonin algorithms for antibiotic therapy decisions. Arch Intern Med 2011;171:1322–31
   PubMedGoogle Scholar
• Schreiber H, Rittirsch D, Flieri M, et al. Complement activation during sepsis in humans. Adv Exp Med Biol 2006;586:217–26
   PubMed Web of Science ®Google Scholar
• Flierl MA, Rittirsch D, Nadeau BA, et al. Functions of the complement components C3 and C5 during sepsis. FASEB J 2008;22:3483–90
   PubMed Web of Science ®Google Scholar
• Yuan J, Gou SJ, Huang J, et al. C5a and its receptors in human anti-neutrophil cytoplasmic antibody ANCA-associated vasculitis. Arthritis Res Ther 2012;14:R140
   PubMed Web of Science ®Google Scholar
• Ward PA. The harmful role of C5a on innate immunity in sepsis. J Innate Immun 2010;2:439–45
   PubMed Web of Science ®Google Scholar
• Yan C, Gao H. New insights for C5a and C5a receptors in sepsis. Front Immunol 2012;3:368
   PubMed Web of Science ®Google Scholar
• Zipursky A, Palko J, Milner R, Akenzua GI. The hematology of bacterial infection in premature infants. Pediatrics 1976;57:839–53
   PubMed Web of Science ®Google Scholar
• Leino L, Sorvajarvi L, Katajisto M, et al. Febrile infection changes the expression of IgG Fc receptors in human neutrophils in vivo. Clin Exp Immunol 1997;107:37–43
   PubMed Web of Science ®Google Scholar
• Cardelli P, Ferraironi M, Amodeo R, et al. Evaluation of neutrophil CD64 expression and procalcitonin as useful markers in early diagnosis of sepsis. Int J Immunopathol Pharmacol 2008;21:43–49
   PubMed Web of Science ®Google Scholar
• Livaditi O, Kotanidou A, Psarra A, et al. Neutrophil CD64 expression and serum IL-8: sensitive early markers of severity and outcome in sepsis. Cytokine 2006;36:283–90
   PubMed Web of Science ®Google Scholar
• Gros A, Roussel M, Sauvadet E, et al. The sensitivity of neutrophil CD64 expression as a biomarker of bacterial infection is low in critically ill patients. Intensive Care Med 2012;38:445–52
   PubMed Web of Science ®Google Scholar
• Gibot S, Bene MC, Noel R, et al. Combination biomarkers to diagnose sepsis in the critically ill patient. Am J Respir Crit Care Med 2012;186:65–71
   PubMed Web of Science ®Google Scholar
• Elghetany M, Davis B. Impact of preanalytical variables on granulocytic surface antigen expression: a review. Cytometry 2005;65:1–5
   PubMedGoogle Scholar
• Streimish I, Bizzarro M, Northrup V, et al. Neutrophil CD64 as a diagnostic marker in neonatal sepsis. Pediatr Infect Dis J 2012;31:777–81
   PubMed Web of Science ®Google Scholar
• Genel F, Atlihan F, Gulez N, et al. Evaluation of adhesion molecules CD64, CD11b and CD62L in neutrophils and monocytes of peripheral blood for early diagnosis of neonatal infection. World J Pediatr 2012;8:72–5
   PubMed Web of Science ®Google Scholar
• Bouchon A, Facchetti F, Weigand MA, et al. TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature 2001;410:1103–7
   PubMed Web of Science ®Google Scholar
• Bopp C, Hofer S, Bouchon A, et al. Soluble TREM-1 is not suitable for distinguishing between systemic inflammatory response syndrome and sepsis survivors and nonsurvivors in the early stage of acute inflammation. Eur J Anaesthesiol 2009;26:504–7
   PubMed Web of Science ®Google Scholar
• Jeong SJ, Song YG, Kim CO, et al. Measurement of plasma sTREM-1 in patients with severe sepsis receiving early goal-directed therapy and evaluation of its usefulness. Shock 2012;37:574–8
   PubMed Web of Science ®Google Scholar
• Gautam N, Olofsson AM, Herwald H, et al. Heparin-binding protein HBP/CAP37: a missing link in neutrophil-evoked alteration of vascular permeability. Nat Med 2001;7:1123–27
   PubMed Web of Science ®Google Scholar
• Linder A, Christensson B, Herwald H, et al. Heparin-binding protein: an early marker of circulatory failure in sepsis. Clin Infect Dis 2009;49:1044–50
   PubMed Web of Science ®Google Scholar
• van Zoelen MAD, Achouti A, van der Poll T. The role of receptor for advanced glycation endproducts RAGE in infection. Crit Care 2011;15:208
   PubMed Web of Science ®Google Scholar
• Bopp C, Hofer S, Weitz J, et al. sRAGE is elevated in septic patients and associated with patient outcome. J Surg Res 2008;147:79–83
   PubMed Web of Science ®Google Scholar
• Narvaez-Rivera RM, Rendon A, Salinas-Carmona MC, Rosas-Taraco AG. Soluble RAGE as a severity marker in community acquired pneumonia associated sepsis. BMC Infect Dis 2012;12:15
   PubMed Web of Science ®Google Scholar
• Jabaudon M, Futier E, Roszyk L, et al. Soluble form of the receptor for advanced glycation end products is a marker of acute lung injury but not of severe sepsis in critically ill patients. Crit Care Med 2011;39:480–8
   PubMed Web of Science ®Google Scholar
• Gutsmann T, Mueller M, Carroll SF, et al. Dual role of lipopolysaccharide LPS-binding protein in neutralization of LPS and enhancement of LPS-induced activation of mononuclear cells. Infect Immun 2001;69:6942–50
   PubMed Web of Science ®Google Scholar
• Sakr Y, Burgett U, Nacul FE, et al. Lipopolysaccharide-binding protein in a surgical intensive care unit: a marker of sepsis? Crit Care Med 2008;36:2014–22
   PubMed Web of Science ®Google Scholar
• Endo S, Suzuki Y, Takahashi G, et al. Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study. J Infect Chemother 2012;18:891–7
   PubMed Web of Science ®Google Scholar
• Shozushima T, Takahashi G, Matsumoto M, et al. Usefulness of presepsin sCD14-ST measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria for systemic inflammatory response syndrome. J Infect Chemother 2011;17:764–9
   PubMed Web of Science ®Google Scholar
• Jones GR, Lowes JA. The systemic inflammatory response syndrome as a predictor of bacteremia and outcome from sepsis. QJM 1996;89:515–22
   PubMedGoogle Scholar
• Dark PM, Dean P, Warhurst G. Bench-to-bedside review: the promise of rapid infection diagnosis during sepsis using polymerase chain reaction-based pathogen detection. Crit Care 2009;13:217
   PubMed Web of Science ®Google Scholar
• Bloos F, Hinder F, Becker K, et al. A multicenter trial to compare blood culture with polymerase chain reaction in severe human sepsis. Intensive Care Med 2010;36:241–7
   PubMed Web of Science ®Google Scholar
• Pletz MW, Wellinghausen N, Welte T. Will polymerase chain reaction PCR-based diagnostics improve outcome in septic patients? A clinical view. Intensive Care Med 2011;37:1069–76
   PubMed Web of Science ®Google Scholar
• Romaschin AD, Harris DM, Ribeiro MB, et al. A rapid assay of endotoxin in whole blood using autologous neutrophil-dependent chemiluminescence. J Immunol Methods 1998;212:169–85
   PubMed Web of Science ®Google Scholar
• Marshall JC, Foster D, Vincent JL, et al. MEDIC study. Diagnostic and prognostic implications of endotoxemia in critical illness: results of the MEDIC study. J Infect Dis 2004;190:527–34
   PubMed Web of Science ®Google Scholar
• Yaguchi A, Yuzawa J, Klein DJ, et al. Combining intermediate levels of the Endotoxin Activity Assay EAA with other biomarkers in the assessment of patients with sepsis: results of an observational study. Crit Care 2012;16:R88
   PubMed Web of Science ®Google Scholar
• Sunden-Cullberg J, Norrby-Teglund A, Rouhiainen A, et al. Persistent elevation of high mobility group box-1 protein HMGB1 in patients with severe sepsis and septic shock. Crit Care Med 2005;33:564–73
   PubMed Web of Science ®Google Scholar
• Karlsson S, Pettila V, Tenhunen J, et al. HMGB1 as a predictor of organ dysfunction and outcome in patients with severe sepsis. Intensive Care Med 2008;34:1046–53
   PubMed Web of Science ®Google Scholar
• van Zoelen MAD, Vogl T, Foell D, et al. Expression and role of myeloid-related protein-14 in clinical and experimental sepsis. Am J Respir Crit Care Med 2009;180:1098–106
   PubMed Web of Science ®Google Scholar
• Tschaikowsky K, Hedwig-Geissing M, Schiele A, et al. Coincidence of pro- and anti-inflammatory responses in the early phase of sepsis: longitudinal study of mononuclear histocompatibility leukocyte antigen-DR expression, procalcitonin, C-reactive protein, and changes in T-cell subsets in septic and postoperative patients. Crit Care Med 2002;30:1015–23
   PubMed Web of Science ®Google Scholar
• Cheron A, Floccard B, Allaouchiche B, et al. Lack of recovery in monocyte human leukocyte antigen-DR expression is independently associated with the development of sepsis after trauma. Crit Care 2010;14:R208
   PubMed Web of Science ®Google Scholar
• Monneret G, Lepape A, Voirin N, et al. Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock. Intensive Care Med 2006;32:1175–83
   PubMed Web of Science ®Google Scholar
• Landelle C, Lepape A, Voirin N, et al. Low monocyte human leukocyte antigen-DR is independently associated with nosocomial infections after septic shock. Intensive Care Med 2010;36:1810–2
   PubMed Web of Science ®Google Scholar
• Hotchkiss RS, Tinsley KW, Swanson PE, et al. Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans. J Immunol 2001;166:6952–63
   PubMed Web of Science ®Google Scholar
• Boomer JS, To K, Chang KC, et al. Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA 2011;306:2594–605
   PubMed Web of Science ®Google Scholar
• Roger PM, Hyvernat H, Breittmayer JP, et al. Enhanced T-cell apoptosis in human septic shock is associated with alteration of the costimulatory pathway. Eur J Clin Microbiol Infect Dis 2009;28:575–84
   PubMed Web of Science ®Google Scholar
• Zhang Y, Li J, Zhou Y, et al. Upregulation of programmed death-1 on T cells and programmed death ligand-1 on monocytes in septic shock patients. Crit Care 2011;15:R70
   PubMed Web of Science ®Google Scholar
• Kessel A, Bamberger E, Masalha M, Toubi E. The role of regulatory T cells in human sepsis. J Autoimmun 2009;32:211–15
   PubMed Web of Science ®Google Scholar
• Monneret G, Finck ME, Venet F, et al. The anti-inflammatory response dominates after septic shock: association of low monocyte HLA-DR expression and high interleukin-10 concentration. Immunol Lett 2004;95:193–8
   PubMed Web of Science ®Google Scholar
• Guignant C, Lepape A, Huang X, et al. Programmed death-1 levels correlate with increased mortality, nosocomial infection and immune dysfunctions in septic shock patients. Crit Care 2011;15:R99
   PubMed Web of Science ®Google Scholar
• Urbonas V, Eidukaite A, Tamuliene I. Increased interleukin-10 levels correlate with bacteremia and sepsis in febrile neutropenia pediatric oncology patients. Cytokine 2012;57:313–5
   PubMed Web of Science ®Google Scholar
• Zeitoun AAH, Gad SS, Attia FM, et al. Evaluation of neutrophilic CD64, interleukin 10 and procalcitonin as diagnostic markers of early- and late-onset neonatal sepsis. Scand J Infect Dis 2010;42:299–305
   PubMed Web of Science ®Google Scholar
• de Pablo R, Monserrat J, Reyes E, et al. Sepsis-induced acute respiratory distress syndrome with fatal outcome is associated to increased serum transforming growth factor beta-1 levels. Eur J Intern Med 2011;23:358–62
   PubMed Web of Science ®Google Scholar
• Toffaletti JG. Blood lactate: biochemistry, laboratory methods, and clinical interpretation. Crit Rev Clin Lab Sci 1991;28:253–68
   PubMed Web of Science ®Google Scholar
• Garrabou G, Moren C, Lopez S, et al. The effects of sepsis on mitochondria. J Infect Dis 2012;205:392–400
   PubMed Web of Science ®Google Scholar
• Hernandez G, Bruhn A, Castro R, et al. Persistent sepsis-induced hypotension without hyperlactatemia: a distinct clinical and physiological profile within the spectrum of septic shock. Crit Care Res Pract 2012;preprint536852
   Google Scholar
• Mikkelsen ME, Miltiades AN, Gaieski DF, et al. Serum lactate is associated with mortality in severe sepsis independent of organ failure or shock. Crit Care Med 2009;37:1670–7
   PubMed Web of Science ®Google Scholar
• Wacharasint P, Nakada TA, Boyd JH, et al. Normal-range blood lactate concentration in septic shock is prognostic and predictive. Shock 2012;38:4–10
   PubMed Web of Science ®Google Scholar
• Nguyen HB, Rivers EP, Knoblich BP, et al. Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Crit Care Med 2004;32:1637–42
   PubMed Web of Science ®Google Scholar
• Arnold RC, Shapiro NI, Jones AE, et al. Emergency Medicine Shock Research Network EMShockNet Investigators. Multicenter study of early lactate clearance as a determinant of survival in patients with presumed sepsis. Shock 2009;32:35–9
   PubMed Web of Science ®Google Scholar
• Jones AE, Shapiro NI, Trzeciak S, et al. Emergency Medicine Shock Research Network EMShockNet Investigators. Lactate clearance vs. central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial. JAMA 2010;303:739–46
   PubMed Web of Science ®Google Scholar
• Puskarich MA, Trzeciak S, Shapiro MI, et al. Emergency Medicine Shock Research Network EMSHOCKNET. Prognostic value and agreement of achieving lactate clearance or central venous oxygen saturation goals during early sepsis resuscitation. Acad Emerg Med 2012;19:252–8
   PubMed Web of Science ®Google Scholar
• Paulus P, Jennewein C, Zacharowski K. Biomarkers of endothelial dysfunction: can they help us deciphering systemic inflammation and sepsis? Biomarkers 2011;16:S11–21
   PubMed Web of Science ®Google Scholar
• Esmon CT. Interactions between the innate immune and blood coagulation systems. Trends Immunol 2004;25:536–42
   PubMed Web of Science ®Google Scholar
• Hook KM, Abrams CS. The loss of homeostasis in hemostasis: new approaches in treating and understanding acute disseminated intravascular coagulation in critically ill patients. Clin Transl Sci 2012;5:85–92
   PubMed Web of Science ®Google Scholar
• Voves C, Wuillemin WA, Zeerleder S. International Society on Thrombosis and Hemostasis score for overt disseminated intravascular coagulation predicts organ dysfunction and fatality in sepsis patients. Blood Coagul Fibrinolysis 2006;17:445–51
   PubMed Web of Science ®Google Scholar
• Stearns-Kurosawa DJ, Osuchowski MF, Valentine C, et al. Pathogenesis of sepsis. Ann Rev Pathol Mech Dis 2011;6:19–48
   PubMed Web of Science ®Google Scholar
• Ranieri VM, Thompson BT, Barie PS, et al. PROWESS-SHOCK Study Group. Drotrecogin alfa activated in adults with septic shock. N Eng J Med 2012;366:2055–64
   PubMed Web of Science ®Google Scholar
• Cocucci E, Racchetti G, Meldolesi J. Shedding vesicles: artefacts no more. Trends Cell Biol 2009;19:43–51
   PubMed Web of Science ®Google Scholar
• Meziani F, Delabranche X, Asfar P, Toti F. Bench-to-bedside review: circulating microparticles – a new player in sepsis? Crit Care 2010;14:R236
   PubMed Web of Science ®Google Scholar
• Kofoed K, Andersen O, Kronborg G, et al. Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective study. Crit Care 2007;11:R38
   PubMed Web of Science ®Google Scholar
• Shapiro NI, Trzeciak S, Hollander JE, et al. A prospective, multicenter derivation of a biomarker panel to assess risk of organ dysfunction, shock, and death in emergency department patients with suspected sepsis. Crit Care Med 2009;37:96–104
   PubMed Web of Science ®Google Scholar
• Osuchowski MF, Welch K, Siddiqui J, Remick DG. Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality. J Immunol 2006;177:1967–74
   PubMed Web of Science ®Google Scholar
• Kellum JA, Kong L, Fink MP, et al. GenIMS Investigators. Understanding the inflammatory cytokine response in pneumonia and sepsis. Arch Intern Med 2007;167:1655–63
   PubMed Web of Science ®Google Scholar
• Tamayo E, Fernandez A, Almansa R, et al. Pro- and anti-inflammatory responses are regulated simultaneously from the first moments of septic shock. Eur Cytokine Netw 2011;22:82–7
   PubMed Web of Science ®Google Scholar
• Wu JF, Ma J, Chen J, et al. Changes of monocyte human leukocyte antigen-DR expression as a reliable predictor of mortality in severe sepsis. Crit Care 2011;15:R220
   PubMed Web of Science ®Google Scholar
• Tang BMP, McLean AS, Dawes IW, et al. The use of gene-expression profiling to identify candidate genes in human sepsis. Am J Respir Care Med 2007;176:676–84
   PubMed Web of Science ®Google Scholar
• Wong HR, Cvijanovich N, Allen GL, et al. Genomics of Pediatric SIRS/Septic Shock Investigators. Genomic expression profiling across the pediatric systemic inflammatory response syndrome, sepsis, and septic shock spectrum. Crit Care Med 2009;27:1558–66
   Google Scholar
• van der Poll T, van Deventer SJH. Cytokines and anticytokines in the pathogenesis of sepsis. Infect Dis Clin North Am 1999;13:413–26
   PubMed Web of Science ®Google Scholar
• Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Eng J Med 2003;348:138–50
   PubMed Web of Science ®Google Scholar
• Andaluz-Ojeda D, Bobillo F, Iglesias V, et al. A combined score of pro- and anti-inflammatory interleukins improves mortality prediction in severe sepsis. Cytokine 2012;57:332–6
   PubMed Web of Science ®Google Scholar
• Gouel-Cheron A, Allaouchiche B, Guignant C, et al. AzuRea Group. Early interleukin-6 and slope of monocyte human leukocyte antigen-DR: a powerful association to predict the development of sepsis after major trauma. PLoS ONE 2012;7:e33095
   PubMed Web of Science ®Google Scholar
• Dwyer J. An infection, unnoticed, turns unstoppable. New York Times 2012;July 12:A15–6. Available from: http://www.nytimes.com/2012/07/12/nyregion/in-rory-stauntons-fight-for-his-life-signs-that-went-unheeded.html?pagewanted=all [last accessed 26 Feb 2013]
   Google Scholar
• Huang DT, Weissfeld LA, Kellum JA, et al. GenIMS Investigators. Risk prediction with procalcitonin and clinical rules in community-acquired pneumonia. Ann Emerg Med 2008;52:48–52
   PubMed Web of Science ®Google Scholar